Preview Mode Links will not work in preview mode
Welcome to the Empowered Patient Podcast with Karen Jagoda.  This show offers a glimpse into the latest innovations in applying generative AI, novel therapeutics and vaccines, and the evolving dynamics in the medical and healthcare landscape. One focus is on how providers, pharmaceutical companies, and payers are empowering patients.  In addition, conversations often focus on how technology is empowering providers, care facilities, pharmaceutical companies, and payers to improve patient outcomes and reduce friction across the healthcare landscape.  Popular Topics Include: Virtual and digital health Use of AI, ML, and robots for clinical and administrative purposes  Value-based healthcare  Precision and stratified medicine Next-generation immuno, cell, and gene therapies Vaccines for infectious diseases and oncology Biomarkers and diagnostics Rare diseases MedTech and medical devices Clinical trials  Population health Chronic conditions l Clinician and staff burnout Smart hospitals The audience includes life science leaders, researchers, medical professionals, patient advocates, digital health entrepreneurs, patients, caregivers, healthcare solution providers, students, journalists, and investors.
  1. All Episodes
  2. Integrating the Patient Perspective in Defining and Promoting Value-Based Healthcare with Rob Abbott ISPOR TRANSCRIPT

Integrating the Patient Perspective in Defining and Promoting Value-Based Healthcare with Rob Abbott ISPOR TRANSCRIPT

Download PDF

Nov 25, 2024

Rob Abbott, CEO and Executive Director at ISPOR, the Professional Society for Health Economics and Outcomes Research, focuses on defining and measuring value in healthcare, including accessibility, affordability, effectiveness, and patient outcomes. HEOR (health economics and outcomes research) can provide data-driven insights to guide healthcare decision-making, reduce bias in research, and consider a broader range of factors like social determinants of health. This can improve treatment adherence, align therapies with what matters most to patients, and support the evaluation of technology used for treatments and predictive analysis of new therapies.  

Rob explains, "I'm excited at both the legacy of work that health economics and outcomes research has contributed to, but I'm particularly excited about the extent to which health economics and outcomes research can provide data-driven insights to highlight health interventions that provide the best health outcomes for the investment made. This is good for managing the expenditure of public resources. Still, even more so, data-driven insights can help us lead to better health outcomes, better treatment protocols, and better health outcomes for patients."

"As health economists and a professional society representing health economists and outcomes researchers, I think we know that historically, we have defined value quite narrowly in terms of a person's physical health, for instance. But we know that increasingly the concept of whole health or a more holistic approach to health is gaining a lot of traction. So, we are actively engaged in expanding the definition of health to include access to housing, social connections and networks, healthy food and lifestyle choices, and things of that nature. So, I think we are beginning to bring some new ideas to the table in terms of how we think about health." 

#ISPOR #Patients #Healthcare #DigitalHealth #GlobalHealth #HEOR #RWE #HealthEconomics #HealthAI #DrugPriceNegotiations

ISPOR.org

Listen to the podcast here

ISPOR